Neurocognitive evaluation of long term survivors of atypical teratoid rhabdoid tumors (ATRT): The Canadian registry experience.

作者: Lucie Lafay‐Cousin , Taryn Fay‐McClymont , Donna Johnston , Chris Fryer , Katrin Scheinemann

DOI: 10.1002/PBC.25441

关键词:

摘要: Background Because atypical teratoid rhabdoid tumor(ATRT) is a rare disease of infancy carrying grim prognosis, focus on long-term outcome, especially neurocognitive remained very limited. With new era multimodality therapy, an increasing proportion patients are now survivors. Procedure Retrospective review neuropsychological (NP) status survivors from the Canadian ATRT registry. Results Among 77 diagnosed between 1995–2012, 16(22%) were survivors. Formal NP assessments available in eight patients. Partial information academic achievement was three additional There four girls and seven boys at median age 27.5 months. Seven underwent complete resection had metastatic disease. All but one received sequential high dose chemotherapy. Five intrathecal Three radiation. Median time formal assessment 7.6 years (3.9–9.8). Full Scale Intellectual Quotient (FSIQ) ranged less than 50–119 (mean 78). Simple expressive receptive language appeared relatively preserved. recently (median diagnosis 2.6 (1.6–4.7)) average to FSIQ, visual spatial skills, visual, verbal memory. other earlier tested 4.9 (3.3–8.3) post-diagnosis FSIQ ranging <50 71. Approximately 50% their scores impaired range. Conclusion Overall this cohort appears significantly school despite absence systematic radiotherapy. Larger series focusing outcome needed current context where treatment strategies include adjuvant Pediatr Blood Cancer 2015;62:1265–1269. © 2015 Wiley Periodicals, Inc.

参考文章(14)
L. Lafay-Cousin, C. Hawkins, A.S. Carret, D. Johnston, S. Zelcer, B. Wilson, N. Jabado, K. Scheinemann, D. Eisenstat, C. Fryer, A. Fleming, C. Mpofu, V. Larouche, D. Strother, E. Bouffet, A. Huang, Central nervous system atypical teratoid rhabdoid tumours: The Canadian Paediatric Brain Tumour Consortium experience European Journal of Cancer. ,vol. 48, pp. 353- 359 ,(2012) , 10.1016/J.EJCA.2011.09.005
Irene Slavc, Monika Chocholous, Ulrike Leiss, Christine Haberler, Andreas Peyrl, Amedeo A. Azizi, Karin Dieckmann, Adelheid Woehrer, Christina Peters, Georg Widhalm, Christian Dorfer, Thomas Czech, Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012. Cancer Medicine. ,vol. 3, pp. 91- 100 ,(2014) , 10.1002/CAM4.161
Sharon L. Gardner, Shahab Asgharzadeh, Adam Green, Biljana Horn, Geoffrey McCowage, Jonathan Finlay, Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Pediatric Blood & Cancer. ,vol. 51, pp. 235- 240 ,(2008) , 10.1002/PBC.21578
Kevin F. Ginn, Amar Gajjar, Atypical Teratoid Rhabdoid Tumor: Current Therapy and Future Directions Frontiers in Oncology. ,vol. 2, pp. 114- 114 ,(2012) , 10.3389/FONC.2012.00114
Tal Finkelstein-Shechter, Adam Gassas, Donald Mabbott, Annie Huang, Ute Bartels, Uri Tabori, Janzen Laura, Cynthia Hawkins, Michael Taylor, Eric Bouffet, None, Atypical Teratoid or Rhabdoid Tumors: Improved Outcome With High-dose Chemotherapy Journal of Pediatric Hematology/Oncology. ,vol. 32, pp. e182- e186 ,(2010) , 10.1097/MPH.0B013E3181DCE1A2
Yi-Wei Chen, Tai-Tong Wong, Donald Ming-Tak Ho, Pin-I Huang, Kai-Ping Chang, Cheng-Ying Shiau, Sang-Hue Yen, None, Impact of radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor (single institute experience). International Journal of Radiation Oncology Biology Physics. ,vol. 64, pp. 1038- 1043 ,(2006) , 10.1016/J.IJROBP.2005.10.001
Stefan Rutkowski, Udo Bode, Frank Deinlein, Holger Ottensmeier, Monika Warmuth-Metz, Niels Soerensen, Norbert Graf, Angela Emser, Torsten Pietsch, Johannes E.A. Wolff, Rolf D. Kortmann, Joachim Kuehl, Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone The New England Journal of Medicine. ,vol. 352, pp. 978- 986 ,(2005) , 10.1056/NEJMOA042176
D. R. Strother, L. Lafay-Cousin, J. M. Boyett, P. Burger, P. Aronin, L. Constine, P. Duffner, M. Kocak, L. E. Kun, M. E. Horowitz, A. Gajjar, Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34. Neuro-oncology. ,vol. 16, pp. 457- 465 ,(2014) , 10.1093/NEUONC/NOT163
Nina S. Kadan-Lottick, Pim Brouwers, David Breiger, Thomas Kaleita, James Dziura, Veronika Northrup, Lu Chen, Megan Nicoletti, Bruce Bostrom, Linda Stork, Joseph P. Neglia, Comparison of Neurocognitive Functioning in Children Previously Randomly Assigned to Intrathecal Methotrexate Compared With Triple Intrathecal Therapy for the Treatment of Childhood Acute Lymphoblastic Leukemia Journal of Clinical Oncology. ,vol. 27, pp. 5986- 5992 ,(2009) , 10.1200/JCO.2009.23.5408